Vanguard Group »

Seres Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.5M 6.3M 0.72
2024-03-31 $5.2M 6.7M 0.77
2023-12-31 $8.4M 6.0M 1.40
2023-09-30 $13M 5.5M 2.38
2023-06-30 $26M 5.4M 4.79
2023-03-31 $33M 5.9M 5.67
2022-12-31 $34M 6.1M 5.60
2022-06-30 $18M 5.3M 3.43
2022-03-31 $36M 5.1M 7.12
2021-09-30 $28M 4.0M 6.96
2021-06-30 $81M 3.4M 23.85
2021-03-31 $70M 3.4M 20.59
2020-12-31 $78M 3.2M 24.50
2020-09-30 $78M 2.8M 28.31
2020-06-30 $11M 2.3M 4.76
2020-03-31 $7.7M 2.2M 3.57
2019-12-31 $7.4M 2.1M 3.45
2019-09-30 $8.4M 2.1M 4.00
2019-03-31 $6.2M 901k 6.88
2018-12-31 $3.9M 851k 4.55
2018-09-30 $7.8M 1.0M 7.59
2018-06-30 $12M 1.4M 8.60
2018-03-31 $13M 1.7M 7.35
2017-12-31 $16M 1.6M 10.13
2017-09-30 $27M 1.7M 16.36
2017-06-30 $18M 1.6M 11.31
2017-03-31 $18M 1.6M 11.27
2016-12-31 $15M 1.5M 10.00
2016-09-30 $17M 1.3M 12.29
2016-06-30 $34M 1.2M 29.06
2015-12-31 $19M 545k 35.06
2015-09-30 $14M 480k 29.61
2015-06-30 $841k 20k 42.05